Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;27(5):807-12.
doi: 10.1007/s00467-011-2075-7. Epub 2011 Dec 27.

NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome

Affiliations

NGAL distinguishes steroid sensitivity in idiopathic nephrotic syndrome

Michael R Bennett et al. Pediatr Nephrol. 2012 May.

Abstract

Background: Idiopathic nephrotic syndrome (NS) is the most common glomerular disorder of childhood. Invasive biopsy remains the diagnostic method of choice for NS. Prognosis correlates with steroid responsiveness, from sensitive (SSNS) to resistant (SRNS). Neutrophil gelatinase-associated lipocalin (NGAL) has been demonstrated to be a powerful risk marker of chronic kidney disease progression. We set out to determine if urine NGAL can distinguish between patients with SRNS, SSNS, and healthy controls.

Methods: Urine and clinical data were collected from patients at Cincinnati Children's Hospital who were recently diagnosed with active nephrotic syndrome as well as healthy controls. Participants included SRNS (n = 15), SSNS (n = 14), and healthy controls (n = 10). Urinary NGAL was measured by ELISA and normalized to creatinine.

Results: Median NGAL was significantly (p < 0.001) higher in SRNS (172.3 ng/ml, IQR 18.8-789) than both SSNS (6.3 ng/ml, IQR 4.9-9.9) and healthy controls (6.5 ng/ml, IQR 4.2-9.1). The area under the curve (AUC) for NGAL to distinguish SRNS from SSNS was 0.91 (p < 0.0001). NGAL levels demonstrated a significant negative correlation with glomerular filtration rate (r = -0.5, p < 0.001). Results did not change with NGAL corrected for urine creatinine and were independent of the degree of proteinuria.

Conclusions: NGAL levels differentiate SSNS from SRNS and correlate with disease severity in SRNS.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Urine NGAL measurements. Median urine NGAL was significantly higher in SRNS than both SSNS and healthy controls (p<0.001). Vertical dot plot overlays represent individual patient urine NGAL levels. NGAL neutrophil gelatinase-associated lipocalin; SRNS steroid resistant nephrotic syndrome; SSNS steroid sensitive nephrotic syndrome
Fig. 2
Fig. 2
The NGAL/creatinine ratio has a high power to distinguish SRNS from SSNS. ROC analysis revealed an AUC of 0.91 (p<0.0001) for the detection of SRNS. The optimal cut-off value was 15 ng/mg NGAL/Cr with a sensitivity and specificity of 0.88. NGAL neutrophil gelatinase-associated lipocalin; SRNS steroid resistant nephrotic syndrome; SSNS steroid sensitive nephrotic syndrome; RDC receiver opening characteristic
Fig. 3
Fig. 3
Urine neutrophil gelatinase-associated lipocalin (NGAL) correlate with disease severity. Median NGAL shows a significant negative correlation with estimated glomerular filtration rate (eGFR) (r=−0.5, p<0.01), indicating NGAL rises as renal function declines in all nephrotic syndrome (NS) patients

Comment in

Similar articles

Cited by

References

    1. Cattran DC, Rao P. Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis. 1998;32:72–79. - PubMed
    1. Hari P, Bagga A, Jindal N, Srivastava RN. Treatment of focal glomerulosclerosis with pulse steroids and oral cyclophosphamide. Pediatr Nephrol. 2001;16:901–905. - PubMed
    1. Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol. 2006;21:344–349. - PubMed
    1. Roberti I, Vyas S. Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus. Pediatr Nephrol. 2010;25:1117–1124. - PubMed
    1. Gipson DS, Gibson K, Gipson PE, Watkins S, Moxey-Mims M. Therapeutic approach to FSGS in children. Pediatr Nephrol. 2007;22:28–36. - PMC - PubMed

MeSH terms

LinkOut - more resources